Diabetes drug metformin shows promise in stopping oral cancer before it starts
NCT ID NCT02581137
First seen Mar 09, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study tests whether metformin, a drug used for diabetes, can prevent oral cancer in people with precancerous mouth lesions like leukoplakia or erythroplakia. About 26 participants took metformin to see if it could shrink or eliminate these lesions. The goal is to stop cancer from forming in the first place.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHROPLAKIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BC Cancer Research Centre
Vancouver, British Columbia, V5Z 1L3, Canada
-
UC San Diego Medical Center - Hillcrest
San Diego, California, 92103, United States
-
University of British Columbia Hospital
Vancouver, British Columbia, V6T 2B5, Canada
-
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.